MedPath

Clinical study of Eladi Kwath in Raktapradar.

Phase 2
Not yet recruiting
Conditions
Inflammatory disease of uterus, except cervix. Ayurveda Condition: RAKTAYONIROGAH/ASRUJA/APRAJA,
Registration Number
CTRI/2025/05/087491
Lead Sponsor
YMT Ayurved Medical College and Hospital
Brief Summary

It is a Single arm clinical study, 42 patients will be taken, Eladi kwath will be given in 2 pal (96ml ~ 100ml), once a day, before food, starting from 5th day of menses upto the next menses for 3 consecutive menstrual cycles

assessment will be done on every 15th day from the 1st baseline visit till 90th day(last visit).

After the last visit USG will be done to evaluate the efficacy of drug



Purpose of study - the purpose of this study is to treat Raktapradar (Menorrhagia) in women.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
42
Inclusion Criteria

Patients with cyclic excessive per vaginal bleeding for more than 7days or quantity more than 80ml or both with or without clots during menstrual cycle Hb 10gm or more Patients with Adenomyosis Fibroid uterus less than 3cms endometriosis and pelvic inflammatory disease.

Exclusion Criteria

Patients with IUCD in utero chronic tubo ovarian mass Tubercular Endometritis Granulosa cell tumor of ovary Patients with known case of Systemic disorder like hypertension liver cirrhosis Patients with known case of Hypothyroidism Hyperthyroidism leukemia thrombocytopenia DUB Suspected cases of Spontaneous threatened or incomplete abortion.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To Evaluate the Efficacy of Eladi Kwath in Raktapradar.To Evaluate the Efficacy of Eladi Kwath in Raktapradar i.e. at baseline, 4 weeks, 8weeks & 12 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

YMT Ayurvedic Medical College and Hospital

🇮🇳

Raigarh, MAHARASHTRA, India

YMT Ayurvedic Medical College and Hospital
🇮🇳Raigarh, MAHARASHTRA, India
Dr Sonal Nakate
Principal investigator
8454090175
nakates18@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.